18f-ffnp

Small moleculeexperimentalImaging agent

Clinical trial activity

3 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0

Earliest trial started Jan 1, 2007 (NCT00968409)

Timeline

2000s

  1. Jan 1, 2007

    Earliest Phase 1 Sponsor(trial)

2010s

  1. Jan 1, 2015

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetRadiopharmaceutical

    radiopharmaceutical

Chemistry & pharmacology

Imaging
18-fluorine

Oral

No

Parenteral

No

Topical

No

Also known as

  • 18f ffnp
  • 18f ffnp
  • 18f-ffnp
  • 18f-ffnp

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06179303Phase 2Jun 1, 2024Breast Cancer Research Foundation, University of Washington
NCT02455453Phase 2Apr 28, 2015Washington University in St. Louis
NCT00968409Phase 1Jan 1, 2007Washington University in St. Louis
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Washington University in St. LouisAcademic/Hospital2222007
Breast Cancer Research FoundationAcademic/Hospital1012024
University of WashingtonAcademic/Hospital1112024
3 organizations
Page 1 / 1